Drug Information

Drug General Information
Drug ID
D07WXI
Former ID
DNC000915
Drug Name
Maribavir
Drug Type
Small molecular drug
Indication Cytomegalovirus infection [ICD10:B25] Phase 3 [522056]
Structure
Download
2D MOL

3D MOL
Formula
C15H19Cl2N3O4
Canonical SMILES
CC(C)NC1=NC2=CC(=C(C=C2N1C3C(C(C(O3)CO)O)O)Cl)Cl
InChI
1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1
InChIKey
KJFBVJALEQWJBS-XUXIUFHCSA-N
CAS Number
CAS 176161-24-3
PubChem Compound ID
471161
PubChem Substance ID
626300, 10306757, 12015036, 14804326, 14853350, 47206634, 50521885, 57405610, 71821537, 93302821, 103651231, 103842355, 109755304, 117368779, 118047322, 126629454, 128390115, 134339815, 134340205, 135078600, 137263772, 137267657, 142220709, 152101613, 160839470, 163099359, 163402541, 164824892, 184528158, 184546347, 198936541, 204433727, 210275491, 210281139, 223554910, 225069495, 227071991, 252345516, 252511550
SuperDrug ATC ID
J05AX10
SuperDrug CAS ID
cas=136470785
Target and Pathway
Target(s) Ganciclovir kinase Target Info Inhibitor [535653]
References
Ref 522056ClinicalTrials.gov (NCT00497796) Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients. U.S. National Institutes of Health.
Ref 535653The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol. 2003 Jan;77(2):905-14.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.